Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Sell price of 6.4 this morning 😖
Hemogenyx Pharmaceuticals Plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
We now look forward to accelerating clinical development of HEMO-CAR-T and to offering patients a potentially life-saving treatment. The removal of the clinical hold was made possible by the hard work and dedication of the entire Hemogenyx Pharmaceuticals team and its Board of Directors and advisors."
About AML and CAR-T Therapy
AML, the most common type of acute leukemia in adults, has poor survival rates (a five-year survival rate of less than 30% in adults) and is currently treated using chemotherapy, rather than the potentially more benign and effective form of therapy being developed by Hemogenyx Pharmaceuticals. The successful development of a new therapy for AML would have a major impact on treatment and survival rates for the disease.
CAR-T therapy is a treatment in which a patient's own T-cells, a type of immune cell, are modified to recognize and kill the patient's cancer cells. The procedure involves: isolating T-cells from the patient; modifying the isolated T-cells in a laboratory using a CAR gene construct (which allows the cells to recognize the patient's cancer); amplifying (growing to large numbers) the newly modified cells; and re-introducing the cells back into the patient.
If it was proved in humans then this would trading at many multiples of the current price. We would be in the pounds not pence.
Plenty of chunky buys going through
£52k buy, that’s a confident purchase.
I could of sold at 6.4 earlier but chose not to as I felt the RNS was excellent, it’s always a gamble if you sell and the price soars and you have to pay a premium to get back in. Sometimes it boils down to good timing and a bit of luck.
Very long auction, I think we will see a breakout over the next few hours.
Back in auction
Everyone set high sell orders to stop any shorters
Shares in HemoGenyx Pharmaceuticals (LSE:HEMO) PLC soared over 17% on Friday morning on news the company’s trials of myeloid leukaemia treatment HEMO-CAR-T could continue.
America’s Food and Drug Administration (FDA) gave the go-ahead for the trial to continue after issues identified in June had been addressed, HemoGenyx said on Friday.
"We are extremely pleased with the FDA's decision,” chief executive Vladislav Sandler commented, “we now look forward to accelerating clinical development of HEMO-CAR-T and to offering patients a potentially life-saving treatment”.
The phase one trial will allow HemoGenyx to continue studying its prospective CAR-T therapy, which sees patients’ T-cells modified to kill cancer, with the treatment aimed at offering an alternative to chemotherapy.
Closed at 3.90, opened straight to auction then went to nearly 7p on the ask. Hope we can get past that today.
Maybe we need Neil777 here with his 200+ posts daily to give us a boost.
What would the royalties be worth too!
I’m holding out for double figures here.
Redx is eligible to receive up to $870 million in development, regulatory and commercial milestone payments from Jazz, with the next milestone being an IND clearance from this program from the U.S. Food and Drug Administration. Redx is also eligible for tiered, mid-single digit percentage royalties based on any future net sales.
*It’s not just the 10 million though is it……..
Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales
It’s not the 10 million though is it…..
Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales
Could sell at 6.4 near opening, what a disappointment to see this dropping back again. I expected more 😩
Could sell at 6.4 on opening